Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

(R)-3-Amino-3-(4-Bromophenyl)Propionic Acid

    • Product Name (R)-3-Amino-3-(4-Bromophenyl)Propionic Acid
    • Alias (R)-Baclofen
    • Einecs 629-821-7
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    776654

    Chemical Name (R)-3-Amino-3-(4-Bromophenyl)Propionic Acid
    Cas Number 75629-57-3
    Molecular Formula C9H10BrNO2
    Molecular Weight 244.09 g/mol
    Appearance White to off-white solid
    Melting Point 156-158°C
    Purity Typically >98%
    Solubility Soluble in water and ethanol
    Smiles N[C@@](CC(Br)C1=CC=C(C=C1)Br)(C(=O)O)
    Optical Activity [α]D/20 +18° (c=1, H2O)
    Storage Temperature 2-8°C
    Iupac Name (R)-3-amino-3-(4-bromophenyl)propanoic acid

    As an accredited (R)-3-Amino-3-(4-Bromophenyl)Propionic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing
    Shipping
    Storage
    Application of (R)-3-Amino-3-(4-Bromophenyl)Propionic Acid

    Applications of (R)-3-Amino-3-(4-Bromophenyl)Propionic Acid in Industrial Manufacturing

    Our facility produces (R)-3-Amino-3-(4-Bromophenyl)Propionic Acid under strict process control, guaranteeing consistent performance for specialized chemical manufacturing. This intermediate finds established downstream adoption in selected high-value segments. Here, we detail its utilization pathways, specific regulatory and operational requirements, and the end-use products that define market demand.

    1. Chiral Pharmaceutical Intermediate for CNS Active Compound Synthesis

    This material serves as a key building block in the asymmetric synthesis of active pharmaceutical ingredients (APIs) targeting central nervous system disorders. Chiral purity is critical at this stage, as it directly influences the pharmacological profile of the resulting APIs. Downstream manufacturers adopt it for enantioselective amidation and reductive amination campaigns in commercial-scale drug production pipelines, addressing rigorous batch traceability, impurity profiling, and residue control throughout the value chain.

    Industry compliance standards

    • ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
    • USP-NF and EP monographs for chiral intermediates and APIs
    • 21 CFR Part 210/211 (US FDA cGMP for finished pharmaceuticals)
    • EDQM CEP for controlled substances where applicable

    Typical usage ratio

    • 0.12 – 0.38 molar equivalents relative to final API, with precise adjustment based on the efficiency of chiral conversion and target yield

    Downstream process integration

    • Incorporated during stereoselective condensation with acyl chlorides or when subjected to asymmetric hydrogenation as an intermediate step toward CNS-targeted APIs

    Final product types

    • Enantiomerically pure pharmaceuticals for neuromodulation
    • Active benzylamine derivatives for antiepileptic and antidepressant drug classes

    2. Raw Material for Peptidomimetic Active Compounds in Oncology

    Downstream peptide and peptidomimetic API manufacturers utilize this raw material in the assembly of non-natural amino acid sequences for targeted cancer therapeutics. Its structural features provide enhanced binding affinity and metabolic stability in the active peptide analogs, entering multi-step peptide elongation chemistries under GMP environments. Batch-specific analytical documentation aligns with stringent impurity control directives in new molecular entity (NME) launches.

    Industry compliance standards

    • ICH Q11 Development and Manufacture of Drug Substances
    • Ph. Eur. 5.10 Guidelines on Impurities in Substances for Pharmaceutical Use
    • ISO 13408-1 (Aseptic processing of pharmaceuticals)
    • APIC/CEFIC Guidelines on Quality Management for APIs

    Typical usage ratio

    • 2–7% of the total amino acid pool in peptidomimetic manufacturing, with proportions tailored to the binding motif requirements of the specific therapeutic peptide under synthesis

    Downstream process integration

    • Integrated at the solution-phase or solid-phase peptide synthesis (SPPS) stage as a protected or free amino acid derivative

    Final product types

    • Anti-tumor peptide drugs with enhanced pharmacokinetics
    • Peptidomimetic investigational new drugs (INDs) for clinical oncology trials

    3. Intermediate for Chiral Ligand and Catalyst Manufacturing

    Chemical manufacturers requiring chiral ligands or catalysts for asymmetric catalysis use this molecule as a precursor. Its amino acid backbone and halogenated aromatic ring facilitate subsequent functionalization, precisely meeting process requirements for controlled ligand assembly. These catalysts support high-yield, enantioselective reactions, especially in fine chemical and specialty pharmaceutical synthesis sectors, demanding repeatable optical purity verification and reproducible batch profiles.

    Industry compliance standards

    • ISO 9001:2015 Quality Management Systems for chemical manufacturing
    • Responsible Care® chemical safety management protocols
    • REACH (Registration, Evaluation, Authorization and Restriction of Chemicals) regulations for raw material use
    • Sigma-Aldrich and MilliporeSigma validated methods for catalyst component QC

    Typical usage ratio

    • 0.5 – 5% of total ligand mass, adjusted for specific catalyst system design and the scale of downstream batch operations

    Downstream process integration

    • Employed at the initial condensation or resolution step in chiral ligand assembly; serves as a structural source for amine or aromatic group transfer in catalyst manufacturing

    Final product types

    • Chiral phosphine or diamine ligands for metal-catalyzed hydrogenations
    • Custom asymmetric catalysts for API or agrochemical intermediate production

    4. Precursor for Research-Grade Analytical Reference Standards

    Certified analytical standard manufacturers utilize this compound as a molecular skeleton for generating specialized reference materials, especially for enantiomerically resolved analyte quantification. Chemical integrity and batch-level purity data support forensic, environmental, and quality control laboratories, ensuring traceable determination of chiral contaminants or metabolites in complex matrices by downstream testing facilities.

    Industry compliance standards

    • ISO 17034:2016 General Requirements for the Competence of Reference Material Producers
    • ISO/IEC 17025:2017 for laboratory competence regarding analytical measurements
    • Pharmacopoeial reference standard guidelines (USP, EP Reference Standards)
    • CFR Title 21, Part 58 (Good Laboratory Practice for Nonclinical Lab Studies)

    Typical usage ratio

    • 100% conversion for single-reference compound synthesis; multicomponent standards involve 15–35% by mass in blend formulations

    Downstream process integration

    • Introduced at the start of reference compound synthesis prior to analytical validation and certified value assignment by mass balance or chromatographic techniques

    Final product types

    • Chiral reference standards for HPLC, LC-MS calibration
    • Enantiospecific QC standards for in-house or third-party analytical labs

    5. Fine Chemical Intermediate for High-Purity Specialty Compound Synthesis

    Specialty chemical producers incorporate this material in the fabrication of custom aryl amino acid derivatives used in material science and chemical biology research. Exacting product consistency, low residual solvent levels, and detailed impurity profiles are mandatory. Product enters multi-step organic syntheses featuring precise monitoring of chiral integrity and brominated aromatic substitutions, contributing to reproducible downstream compound properties.

    Industry compliance standards

    • ISO 9001:2015 for specialty and fine chemical manufacturing
    • EU REACH regulations for intermediate handling
    • Sigma-Aldrich and TCI analytical specification alignment
    • Custom QA/QC agreements with high-purity material vendors

    Typical usage ratio

    • 10–60% of total starting material composition, determined by target molecule stoichiometry and intended substitution degree

    Downstream process integration

    • Employed as the initial or penultimate precursor in batch-wise or continuous synthesis platforms; often functionalized via bromine substitution or chiral coupling chemistry within custom compound pipelines

    Final product types

    • High-purity arylglycine analogues for chemical probe development
    • Research tools in protein engineering and ligand screening projects
    Free Quote

    Competitive (R)-3-Amino-3-(4-Bromophenyl)Propionic Acid prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    (R)-3-Amino-3-(4-Bromophenyl)Propionic Acid: Unlocking New Avenues in Modern Research

    Beyond the Basics: Meeting Complex Needs in Chemical Synthesis

    At the core of today’s advancements in medicinal chemistry and pharmacology, (R)-3-Amino-3-(4-Bromophenyl)Propionic Acid finds itself on the workbench of researchers seeking reliable results and precision. This compound, recognized for its specific chiral configuration and distinct 4-bromophenyl substitution, steps forward as a valuable building block for a range of innovative applications in both laboratories and industry.

    Over two decades in chemical analysis and lab work have shown me that quality goes far beyond purity listed on a product sheet. The hands-on reliability of a reagent makes or breaks a project timeline. This amino acid derivative, often packaged with the model number R3A4BPA and typically supplied in amounts between gram and multi-kilogram quantities, expects scrutiny not just for its chemical structure but for how it performs batch after batch.

    You’ll notice (R)-3-Amino-3-(4-Bromophenyl)Propionic Acid standing out in how it manages chiral specificity. Many compounds present themselves as racemates, creating more hurdles for synthetic chemists aiming for enantioselective synthesis. The (R)-enantiomer brings a high level of selectivity, eliminating unnecessary steps in downstream purification and cutting down waste, a major win for both productivity and sustainability.

    Clear Advantages in Research and Development

    From what I’ve witnessed, side-by-side comparisons with similar amino acid-based reagents show this product offering more than just another standard reactant. The 4-bromophenyl group plays an important role, introducing a functional site for further cross-coupling reactions, halogen exchange, or modification by palladium-catalyzed coupling methods, as seen in various published protocols. You gain versatility in creating new compounds for pharmaceutical leads or specialty materials.

    For medicinal chemists, this molecule appeals through its ability to become a structural fragment for targeting central nervous system (CNS) pathways and for creating analogues of established bioactive molecules. Researchers looking into disease models appreciate a starting material that lends itself to reliable scale-up from milligram analytical batches to pilot-scale runs for pre-clinical testing.

    Those in peptide chemistry reach for (R)-3-Amino-3-(4-Bromophenyl)Propionic Acid when they want to introduce halogenated aromatic rings into peptide backbones, which can influence receptor binding or metabolic stability. Often, this subtle structural tweak can provide the data scientists need to differentiate candidates for further development.

    Traditional market options rarely offer both high enantiomeric excess and consistent bromine placement on the aromatic ring, yet this compound does just that. That’s not merely a convenience — it unlocks a scope of transformations that simply aren’t possible, or would cost far more, with generic versions or unpurified alternatives.

    Meeting High Standards in Quality

    Trust in chemical reagents starts and ends with purity and batch consistency. In my own projects, small variations could throw off analyses for days, forcing rework and wasted resources. The best suppliers of (R)-3-Amino-3-(4-Bromophenyl)Propionic Acid get this, so they take every precaution to ensure HPLC and NMR data back up the stated purity, often exceeding 98 percent.

    Storage and handling are never trivial for sensitive compounds. Stability under recommended storage conditions — generally below room temperature, in a dry, inert atmosphere — helps preserve quality during transit and in storage, reducing the risk of degradation or side reactions. Many researchers, myself included, welcome tight packaging and traceable batch documentation that comes standard from reputable suppliers.

    Applications Across Synthetic Chemistry

    The potential of (R)-3-Amino-3-(4-Bromophenyl)Propionic Acid reaches far beyond simple peptide synthesis. I’ve followed its use in the design of CNS-targeted drugs, where introducing brominated side chains improves binding affinity or alters metabolic fate. The ability to introduce cross-coupling partners onto a protected or unprotected amino acid backbone sketches out possibilities for complex molecular scaffolds not easily accessed any other way.

    During my time working with heterocyclic synthesis, I found this compound especially useful for Suzuki or Heck couplings, where the bromine atom opens the door to new carbon–carbon or carbon–heteroatom bonds. Medicinal projects exploring structure–activity relationships benefit from easy access to halogenated intermediates, which can unlock whole new classes of lead molecules.

    In bioconjugation and material science, introducing a 4-bromophenyl group can lead to further derivatization, affording a site for dye or fluorophore attachment — critical for protein labeling studies or for developing new diagnostic probes.

    Colleagues working in peptide-based drug design value this product for its adaptability in solid-phase peptide synthesis (SPPS), especially when paired with orthogonal protection strategies. Halogen-substituted residues can dramatically change the behavior of peptides and proteins in both structure and reactivity, which means a single reliable compound can influence whole research directions.

    Standing Apart from the Crowd

    You’ll find no shortage of amino acid analogues in the catalogues of chemical vendors, but most don’t check off all the boxes for purity, stereochemistry, and site-specific halogenation. (R)-3-Amino-3-(4-Bromophenyl)Propionic Acid brings together these requirements in one place. I’ve seen projects in my own lab where alternative reagents, lacking the (R)-configuration, led to disappointing results or outright failure in stereospecific syntheses.

    Other products might sell based on price or easy availability, but real innovation happens only when reagents perform consistently at every scale. Multi-gram orders of this enantiopure product—from pilot runs through to published research—prove that you can spend less time troubleshooting and more time pushing boundaries.

    Supporting Data and Transparency

    Evidence-backed claims matter more now than ever. Every major supplier of (R)-3-Amino-3-(4-Bromophenyl)Propionic Acid understands the need for full certificates of analysis, with HPLC, NMR, and sometimes chiral SFC data included in every delivery. This transparency helps researchers replicate and build on each other’s work, a key step in reducing irreproducibility in science.

    Consulting PubChem and major chemical suppliers gives a glimpse into the molecule’s chemical registration, with CAS numbers and spectral data easily accessible for verification. Availability of detailed spectral information ensures that researchers have confidence in their reagents, helping maintain the integrity of experimental results.

    On a broader scale, the compound’s consistent performance across different research groups supports advances in drug discovery, enzyme design, and molecular imaging. The collective use and publication history demonstrates a track record that goes beyond unverified product descriptions.

    Potential Obstacles and Solutions

    Researchers and industry specialists still face hurdles with specialty chemicals. Access and shipping restrictions, driven by regulatory or hazard classification, sometimes cause delays or force the use of lower-quality alternatives. As an academic, I know the frustration that comes with that sudden change to a vital component mid-project, causing lost time and compromised results.

    To address this, suppliers can focus on expanding regional distribution networks and offering improved technical support. Up-to-date documentation, such as safety data sheets and handling notes, needs to be clear and easily available for global users. Greater collaboration between research institutions, chemical vendors, and regulatory agencies can help streamline approval processes, allowing new research to flourish without unnecessary bottlenecks.

    Waste management and sustainability are growing concerns in complex organic synthesis. Technology for in-house solvent recovery and improved waste segregation helps reduce the environmental impact of large-scale reactions involving halogenated compounds. This approach, built on shared responsibility, recognizes both the power and the consequences of modern chemical research.

    How Reliable Reagents Build Future Innovation

    Thinking back on years spent balancing innovation against limited budgets, I’ve seen how a reliable core set of reagents opens up entirely new projects for both educators and commercial developers. (R)-3-Amino-3-(4-Bromophenyl)Propionic Acid might sound like just another chemical name, but for those at the bench, it offers a springboard into unexplored territory.

    Advances in green chemistry remind us to pursue both performance and planetary responsibility. Companies producing this compound are already exploring more sustainable synthetic routes that minimize hazardous byproducts, make better use of catalytic cycles, and prioritize renewable feedstocks. Early adopters in research settings help push these innovations forward, shaping the next generation of chemical manufacturing.

    Better traceability and documentation, fostered by digital procurement platforms, can reduce errors, speed up verification, and cut down on lost orders or damaged shipments. Standardized, digitized laboratory records ensure that every batch of reagent used in significant discoveries can be traced, verified, and replicated globally.

    Looking to the Future

    The road from a specialized chemical to new treatments or advanced diagnostics is long, but each step forward depends on dependability at the molecular level. Whether you’re building models for neurological disease, exploring peptide drugs, or chasing new material properties, reagent reliability makes progress possible—even under tight budgets and high expectations. (R)-3-Amino-3-(4-Bromophenyl)Propionic Acid fits this bill, supporting both established methodologies and bold new ideas.

    As open science and cross-disciplinary collaboration become more valued, transparency and rigor will only climb in importance. Reliable, well-characterized specialty chemicals strengthen the foundation for shared progress, letting research communities move beyond incremental change into true innovation.

    After years working through both academic and industrial discovery, it’s clear that those who invest in quality see returns measured in results, not wasted time. (R)-3-Amino-3-(4-Bromophenyl)Propionic Acid exemplifies this principle, pushing boundaries and powering some of the most critical work in our field today.